Browse Studies — Arctuva

Phase 1

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of IBI3042 in Healthy Adult Participants

This is a randomized, investigator- and participant-blinded, placebo-controlled, parallel-group, dose-escalation Phase 1 study to evaluate the safety, tolerabi…

Healthy Volunteers (HV)

Estimated

~$10 – $8,750

Fortvita Biologics (USA)Inc.NCT07842393

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood tes…

Breast Cancer (Locally Advanced or Metastatic)Healthy Volunteers (HV)Unhealthy Volunteers+1 more

Estimated

~$10 – $750

University of Maryland, BaltimoreNCT07374796

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test.…

Lung CancerLung Cancer ScreeningHealthy Volunteers (HV)+1 more

Estimated

~$10 – $750

University of Maryland, BaltimoreNCT07008664

Phase 1

A Phase 1, Open-label, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Japanese and Chinese Participants.

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese…

Healthy Volunteers (HV)

Estimated

~$10 – $8,750

Jade Biosciences, Inc.NCT07525947